telehealth services compounded tirzepatide injections Compounded Tirzepatide (GLP-1/GIP) Injections |

While Mounjaros primary focus is diabetes treatment, its potential for weight management is promising

Zepbound is a prescription obesity drug containing tirzepatide, manufactured by Eli Lilly and approved for chronic weight management after receiving FDA approval for use in eligible adults with obesity or overweight with certain related conditions

FOOD AND DRUG ADMINISTRATION HAS APPROVED FINASTERIDE TO TREAT MALE PATTERN BALDNESS SOURCE: American Academy of Dermatology Association

Realistic Long-Term Weight Loss Expectations on Semaglutide Most patients using semaglutide continuously lose weight for twelve to twenty months before reaching a plateau, at which point weight stabilizes rather than increases